European Union industry: doing well but could do better
This article was originally published in Clinica
US companies controlled 43% of the total EU medical devices market in 1993, while EU businesses controlled 21% of the US medical devices market. Although three-quarters of the European medical device market was supplied by European production in 1993, 26% of EU domestic production was accounted for by US companies.
You may also be interested in...
Lannett will launch a further seven products in fiscal 2021, after launching four products recently in the first quarter of FY21. The company also plans to pay off its Term Loan ‘A’ in full, by the end of November 2020.
Pfizer has now received a formal European Commission approval for its Nyvepria biosimilar pegfilgrastim. The approval puts the firm in direct competition with several other versions of the Neulasta original.
AstraZeneca's research head admits that the half dose approach was a lucky mistake – but one that could boost the vaccine's effectiveness and supplies. The US regulator may not be persuaded, however.